The exercise period for Moberg Pharma's warrants of series 2023:1 (TO 2) begins today
Today, the exercise period for Moberg Pharma AB (publ)'s ("Moberg Pharma" or the "Company") warrants of series 2023:1 begins. The exercise period runs during the period from and including June 5[th], 2024, up to and including June 19[th], 2024. The last day for trading in warrants of series 2023:1 on Nasdaq Stockholm is June 17[th], 2024.In 2023, Moberg Pharma carried out a rights issue of units which was oversubscribed to approximately 130%. Each unit consisted of one (1) ordinary share and one (1) warrant in Moberg Pharma. One (1) warrant entitles the holder to subscribe for one (1) new